About us

GLYcoDiag Company

Created in 2005, GLYcoDiag is an innovative company which has been the first to launch lectin array research, application and services studies in France. Our business is based on a self-financing model and we are certified as a provider of research projects by the French research ministry.

Our Aim

GLYcoDiag is looking for a constant improvement of its expertise in glycosciences in order to provide our customers the more innovative and adapted services and products.

Our initial goals:

  • To reach a leading position in applied glycoanalysis
  • To develop a technology platform focused on a lectin-based glycoanalysis
  • To integrate glycoanalysis in R&D and Quality Control processes
  • To develop and produce analytical and diagnostic “lectin- and glyco-based” tests

Our Team

Manager        Ludovic Landemarre, Ph.D.

After a Ph D. in immunoanalysis and glycobiology obtained in 1996, he spend nine years as head of laboratory then scientific and technical director in a subsidiary of Stago group. During this time, L. Landemarre launch a new customized antibodies services department and lead R and D projects for diagnostic (kits, antibodies, reagents) and vaccination (veterinary field) purposes. With his skills for management (laboratory and projects) and specific experience in the fields of biochemistry, immunoanalysis and glycoanalysis, L Landemarre founded GLYcoDiag in august 2005.

Research and development manager          Alexiane Decout, Ph.D.

Alexiane Decout has joined GLYcoDiag in 2016. During her PhD in collaboration bewteen InvivoGen and the Institute of Pharmacology and Structural Biology in Toulouse, she studied the interactions of mycobacterial glycoconjugates with the C-type lectins Mincle, Dectin-1 and Dectin-2. She will develop the range of lectin-based products proposed by GLYcoDiag.

Project manager          Mélanie Lecerf, MSc.

Melanie Lecerf has joined GLYoDiag in 2016 after one year of apprenticeship.

She obtained her master in chemistry of bioactives molecules with a specialization in bioactives and cosmetics from University of Orléans. She will be in charge of microbiological and glycobiological projects.

ImmunoShape early stage researcher         Blanka Didak, MSc.

Blanka Didak has joined GLYcoDiag in 2015 as PhD student of IMMUNOSHAPE project. In GLYcoDiag, Blanka will develop new neoglycoproteins with glycan motifs which will be recognized by C-type lectins. In collaboration with other partners of project, she will develop C-type lectins microarray with selected neoglycoproteins for specific applications.

 Scientific support          Eric Duverger, Ph.D.

Ph.D. from University of Orléans in 1995. During this work, he evidenced a new glycodependent nuclear import pathway wich could involved nucleocytosolic lectins. Since 1997, he is assistant professor in cell biology and biochemistry at the University of Orléans. His research area include plant lectin isolation, lignan biosynthesis and nuclear import of plasmids mediated by karyophilic sugars. Since 2013, he has joined the glycobiochemistry lab (Université d’Orléans) and develops both glycochemistry and glycobiology in collaboration with GLYcoDiag.

Scientific board       

Prof. Richard Daniellou

Internationally recognized expert in Glycosciences, Prof. Richard Daniellou received a degree in Biochemistry and a PhD (2003) in Organic Chemistry from the University of Paris XI. After two years as a postdoctoral researcher at the University of Saskatchewan (Canada), he was offered an Assistant Professor position at the ENSC of Rennes (France). In 2010 he defended a habilitation and was promoted Full Professor of Biochemistry at the Organic and Analytical Chemistry Institute of Orléans (France) in 2011. His main interest for carbohydrate-active enzymes as biocatalysts for chemo-enzymatic synthesis of glycoconjugates led him to the creation of the research group named Enzymology and Glycobiochemistry. He is currently co-author of 55 publications and 3 patents.

Prof. Michel Monsigny

International leader in Glycobiology, M. Monsigny is Professor (emeritus) of Biochemistry/Glycobiology at the University of Orléans, France. M. Monsigny is author (or co-author) of over 200 papers and of 20 patents. Prof. Monsigny was head of the “glycoconjugates and endogenous lectins” department, Centre de Biophysique Moléculaire, CNRS. His research topics include neoglycoprotein and glycosynthon synthesis, plant lectins, endogenous animal lectins, intracellular glycoconjugate trafficking, and sugar-mediated gene therapy.

Glycodiag's team GLYcoDiag’s team with one of our research partners team of Pr. Daniellou.